Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
17/08/2026
The Clearing Corporation of the Bombay Stock Exchange has launched a short-term contract for its securities lending segment.
Latest
5 m ago
Lei Jun: On March 28, 2024, the Xiaomi SU7 was officially released. As of today, in just 28.5 months, the delivery volume of the Xiaomi SU7 series has exceeded 500,000 units.
6 m ago
On August 17, AstraZeneca announced the official launch of Tezspire (generic name: tezelizumab injection) in China. In March 2026, tezelizumab was approved in China for two indications based on positive results from the DIRECTION and WAYPOINT Phase III clinical studies: for the maintenance treatment of severe asthma in adults and adolescents aged 12 years and older; and in combination with intranasal corticosteroids, for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP) whose disease is not adequately controlled by systemic corticosteroids and/or surgery.
6 m ago
Hong Kong Stock Movement | China Qinfa (00866.HK) rises nearly 15% again, expects post-tax profit for the first half of the year to be no more than 290 million yuan.
6 m ago
Establishing a high-quality development model in the industry, Geely Automobile's revenue in the first half of 2026 exceeded 170 billion yuan, with a core net profit attributable to shareholders soaring by 46%.
7 m ago
AstraZeneca announces the official launch of Tezspire in China.
See all latest